262 related articles for article (PubMed ID: 36048170)
1. CRISPRthripsis: The Risk of CRISPR/Cas9-induced Chromothripsis in Gene Therapy.
Amendola M; Brusson M; Miccio A
Stem Cells Transl Med; 2022 Oct; 11(10):1003-1009. PubMed ID: 36048170
[TBL] [Abstract][Full Text] [Related]
2. Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing.
Leibowitz ML; Papathanasiou S; Doerfler PA; Blaine LJ; Sun L; Yao Y; Zhang CZ; Weiss MJ; Pellman D
Nat Genet; 2021 Jun; 53(6):895-905. PubMed ID: 33846636
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9 can cause chromothripsis.
Urnov FD
Nat Genet; 2021 Jun; 53(6):768-769. PubMed ID: 34103715
[No Abstract] [Full Text] [Related]
4. Advances in therapeutic application of CRISPR-Cas9.
Sun J; Wang J; Zheng D; Hu X
Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
[TBL] [Abstract][Full Text] [Related]
5. CRISPR therapies march into clinic, but genotoxicity concerns linger.
Sheridan C
Nat Biotechnol; 2021 Aug; 39(8):897-899. PubMed ID: 34267391
[No Abstract] [Full Text] [Related]
6. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
7. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
8. Advances in therapeutic CRISPR/Cas9 genome editing.
Savić N; Schwank G
Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
[TBL] [Abstract][Full Text] [Related]
9. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
10. [Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals].
Li GL; Yang SX; Wu ZF; Zhang XW
Yi Chuan; 2020 Jul; 42(7):641-656. PubMed ID: 32694104
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
Liu W; Yang C; Liu Y; Jiang G
Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
[TBL] [Abstract][Full Text] [Related]
14. Temperature effect on CRISPR-Cas9 mediated genome editing.
Xiang G; Zhang X; An C; Cheng C; Wang H
J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
[TBL] [Abstract][Full Text] [Related]
15. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-induced DNA breaks trigger crossover, chromosomal loss, and chromothripsis-like rearrangements.
Samach A; Mafessoni F; Gross O; Melamed-Bessudo C; Filler-Hayut S; Dahan-Meir T; Amsellem Z; Pawlowski WP; Levy AA
Plant Cell; 2023 Oct; 35(11):3957-3972. PubMed ID: 37497643
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas based gene editing: marking a new era in medical science.
Prasad K; George A; Ravi NS; Mohankumar KM
Mol Biol Rep; 2021 May; 48(5):4879-4895. PubMed ID: 34143395
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas gene therapy.
Zhang B
J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
[TBL] [Abstract][Full Text] [Related]
20. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
